View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/SAMHSA RIN: 0930-AA36 Publication ID: Fall 2022 
Title: Mandatory Guidelines for Federal Workplace Drug Testing Programs--Urine 
Abstract:

This action proposes to establish the scientific and technical guidelines for the inclusion of urine specimens in the Mandatory Guidelines for Federal Workplace Drug Testing Programs and standards for certification of laboratories engaged in drug testing for federal agencies.

 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: None     (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: sec. 503 of Pub. L. 100-71    5 U.S.C. 7301   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  04/07/2022  87 FR 20560   
NPRM Comment Period End  06/06/2022 
Final Rule  03/00/2023 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Ron Flegel
Director, Division of Workplace Programs, CSAP
Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
5600 Fishers Lane, Room 16N01,
Rockville, MD 20857
Phone:240 276-2611
Email: ron.flegel@samhsa.hhs.gov